Personalized Prehabilitation Improves Tolerance to Chemotherapy in Patients with Oesophageal Cancer.

Grigorios ChristodoulidisLaura J HallidayAthina A SamaraNeel BhuvaWon-Ho Edward ParkKrishna Moorthy

Published in: Current oncology (Toronto, Ont.) (2023)

The findings of this exploratory study suggest that prehabilitation is associated with better tolerance for chemotherapy. Further research is needed to establish the long-term impact of prehabilitation on oncological outcomes.

Keyphrases

locally advanced
papillary thyroid
rectal cancer
squamous cell
radiation therapy
radical prostatectomy
type diabetes
adipose tissue
metabolic syndrome
young adults
weight loss
lymph node metastasis